The low expression of HLA-I and CD8+ T cells in cervical cancer tissue may indicate that tumor cells exhibit HLA-I downregulation, with a resultant loss of antigen presentation capability and downregulation of endogenous peptide processing machinery for MHC presentation. The gene discussed is CD8A; the disease is cervical carcinoma.